Accessibility Menu
Medtronic logo

Medtronic(NYSE) MDT

Current Price$82.31
Market Cap$106.62BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1977)+121,268%
5 Year-23%
1 Year-4%
1 Month+6%
Medtronic last closing stock price
MetricPriceDate
Last closeUSD 83.292026-07-20
Medtronic stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.34%USD 83.572026-07-13
1 month+5.93%USD 78.632026-06-18
3 month+2.49%USD 81.272026-04-21
Year to date-11.8%USD 94.432025-12-31
1 year-4.03%USD 86.792025-07-18
3 year+3.33%USD 80.612023-07-21
5 year-23.33%USD 108.632021-07-21
Since inception+121,267.74%USD 0.071977-11-21

Medtronic Financials at a Glance

Market Cap

$106.62BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$36.36B

Net Income (TTM)

$4.80B

EPS (TTM)

$3.73

P/E Ratio

22.35

Dividend

$2.85

Beta (Volatility)

0.55 (Low)

Price

$82.31

Volume

5,840,408.593

Open

$82.49

Previous Close

$82.35

Daily Range

$81.49 - $83.29

52-Week Range

$73.31 - $106.33

Estimated Earnings Date

Aug 18, 2026

MDT News

dividend-kings-infographic

Dividend Kings of 2026

Matt DiLalloJul 2, 2026
A person calculating their finances.

Worried About a Market Crash? These 3 Dividend Stocks Could Help Reduce Your Risk

David Jagielski, CPAJun 17, 2026
Robots taking care of plants in a greenhouse.jpg

The Largest Robotics Companies in the World

Lyle DalyJun 15, 2026
Doctor going over results with a patient.

Why Medtronic Stock May Have Just Become the Best Buy in the Entire Healthcare Sector

David Jagielski, CPAJun 8, 2026
Surgeon and stock analyst

Can Medtronic Finally Challenge Intuitive Surgical's Robotic Surgical Systems Dominance?

Justin PopeJun 8, 2026
A person holding cash.

3 High-Yielding Dividend Stocks That Just Raised Their Payouts

David Jagielski, CPAJun 5, 2026
25_03_02 A hand building a puzzle vertically _MF Dload GettyImages-1054149870-1200x750-7d59391

Why Savvy Investors Are Loading Up on This Beaten-Down Stock

Reuben Gregg BrewerMay 9, 2026
GettyImages-874031176-1201x818-e30f643

3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery

Jack DelaneyApr 25, 2026
Page 1

MDT: Motley Fool Moneyball Superscore

71

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medtronic

Medtronic makes tools to help people manage health conditions. Doctors use their devices to treat heart and brain problems. These products help patients live longer and healthier lives.

What Medtronic Makes

  • Cardiovascular Portfolio: Devices for heart rhythm, heart failure, and vascular health; generated $14 billion in net sales during fiscal year 2026.
  • Neuroscience Portfolio: Systems for spinal surgery, brain modulation, and pain management; generated $10.3 billion in net sales during fiscal year 2026.
  • Medical Surgical Portfolio: Advanced surgical tools, stapling devices, and robotic platforms; generated $8.8 billion in net sales during fiscal year 2026.
  • Diabetes Business: Insulin pumps and continuous glucose monitoring systems; generated $3.1 billion in net sales during fiscal year 2026.

Growth and Global Expansion

  • Separated the Diabetes Business into an independent company, MiniMed Group, Inc., following an initial public offering in March 2026.
  • Acquired CathWorks Ltd. in April 2026 to improve how coronary artery disease is diagnosed and treated.
  • Launched the Hugo robotic-assisted surgery system designed for a broad range of soft-tissue procedures.
  • Acquired Scientia Vascular and initiated the pending purchase of SPR Therapeutics to strengthen the neuroscience division.

Scaling Innovation Worldwide

The company distributes medical technology and therapies to patients in over 150 countries. It integrates artificial intelligence and data analytics into its products to monitor conditions and customize patient care remotely.

The Financial Scorecard

  • Total net sales reached $36.4 billion in fiscal year 2026, up 8% year-over-year.
  • Net income was $4.8 billion in fiscal year 2026, up from $4.7 billion in fiscal year 2025.
  • Free cash flow was $5.4 billion in fiscal year 2026, up from $5.2 billion in fiscal year 2025.
  • Research and development spending increased to $2.9 billion in fiscal year 2026.

Bottom Line

Medtronic has evolved into a global healthcare technology leader by integrating software and robotics into traditional medical devices. The company continues to refine its business to focus on high-growth surgical and diagnostic categories.

AI Generated • Jun 19, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

95,000

CEO

Geoffrey Straub Martha

Website

www.medtronic.com

Headquarters

Galway, GA H91 4K49, IE

MDT Financials

Key Financial Metrics (TTM)

Gross Margin

65.02%

Operating Margin

17.78%

Net Income Margin

13.20%

Return on Equity

9.85%

Return on Capital

8.35%

Return on Assets

5.16%

Earnings Yield

4.47%

Dividend Yield

3.42%

Payout Ratio

75.81%

Stock Overview

Market Cap

$106.62BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.28B

Volume

5.84M

Avg. Volume

10.27M

Financials (TTM)

Gross Profit

$23.64B

Operating Income

$6.47B

EBITDA

$9.72B

Operating Cash Flow

$7.33B

Capital Expenditure

-$1.90B

Free Cash Flow

$5.43B

Cash & ST Invst.

$9.22B

Total Debt

$27.96B

Medtronic Performance Analysis

Medtronic annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-04-30USD 31,227,000,000-1.4%
20242024-04-30USD 32,364,000,0003.6%
20252025-04-30USD 33,537,000,0003.6%
20262026-04-30USD 36,364,000,0008.4%
Medtronic sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-07-25-3.9%
Q22025-10-244.5%
Q32026-01-230.6%
Q42026-04-248.7%
Medtronic annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-04-30USD 2.82-24.4%
20242024-04-30USD 2.76-2.0%
20252025-04-30USD 3.6130.8%
20262026-04-30USD 3.733.1%
Medtronic sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-07-25-1.2%
Q22025-10-2432.1%
Q32026-01-23-16.8%
Q42026-04-247.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

$9.81B

+9.9%

Gross Profit

$7.44B

+28.7%

Gross Margin

75.87%

N/A

Market Cap

$106.62BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.12M

N/A

Employees

95,000

N/A

Net Income

$1.24B

+17.6%

EBITDA

$2.64B

+15.9%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

$9.22B

+2.8%

Total Debt

$27.96B

-1.9%

Accounts Receivable

$6.64B

+2.0%

Inventory

$5.95B

+8.7%

Long Term Debt

$26.17B

+2.1%

Short Term Debt

$1.79B

-37.8%

Return on Assets

5.16%

N/A

Return on Invested Capital

7.95%

N/A

Free Cash Flow

$2.09B

+0.8%

Operating Cash Flow

$2.57B

+1.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SNYSanofi
$43.75-0.52%
GSKGSK plc
$50.78+1.48%
MCKMcKesson Corporation
$828.84-0.32%
SYKStryker Corporation
$314.58-1.43%

Trending Stocks

Symbol / CompanyPricePrice Chg
PATHUiPath
$12.04-0.01%
TAT&T
$22.26+0.01%
NOKNokia
$10.63+0.05%
MARAMara Holdings
$12.25+0.05%

Questions About MDT

What is the current price of Medtronic?

Medtronic is trading at $82.35 per share.

What is the 52-week range for Medtronic?

Over the past 52 weeks, Medtronic has traded between $73.31 and $106.33.

How much debt does Medtronic have?

As of the most recent reporting period, Medtronic reported total debt of $29.15B.

How much cash does Medtronic have on hand?

Medtronic reported $1.95B in cash and cash equivalents in its most recent financial results.

What is Medtronic’s dividend yield?

Medtronic currently has a dividend yield of 3.42%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services